These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30191743)

  • 21. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
    Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
    PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eliciting unnatural immune responses by activating cryptic epitopes in viral antigens.
    Lee YJ; Yu JE; Kim P; Lee JY; Cheong YC; Lee YJ; Chang J; Seong BL
    FASEB J; 2018 Sep; 32(9):4658-4669. PubMed ID: 29570395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
    Altenburg AF; Magnusson SE; Bosman F; Stertman L; de Vries RD; Rimmelzwaan GF
    Clin Exp Immunol; 2017 Oct; 190(1):19-28. PubMed ID: 28665497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A conserved matrix epitope based DNA vaccine protects mice against influenza A virus challenge.
    Kumar P; Khanna M; Kumar B; Rajput R; Banerjea AC
    Antiviral Res; 2012 Jan; 93(1):78-85. PubMed ID: 22086129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.
    Deliyannis G; Boyle JS; Brady JL; Brown LE; Lew AM
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6676-80. PubMed ID: 10823919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection.
    Ben-Yedidia T; Marcus H; Reisner Y; Arnon R
    Int Immunol; 1999 Jul; 11(7):1043-51. PubMed ID: 10383936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
    Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J
    J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The virus-induced signaling adaptor molecule enhances DNA-raised immune protection against H5N1 influenza virus infection in mice.
    Luo M; Qu X; Pan R; Zhu D; Zhang Y; Wu J; Pan Z
    Vaccine; 2011 Mar; 29(14):2561-7. PubMed ID: 21303708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
    Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
    Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic recombinant vaccines against viral agents.
    Arnon A; Levi R
    Int Arch Allergy Immunol; 1995 Dec; 108(4):321-6. PubMed ID: 7580302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease.
    Davtyan H; Ghochikyan A; Cadagan R; Zamarin D; Petrushina I; Movsesyan N; Martinez-Sobrido L; Albrecht RA; García-Sastre A; Agadjanyan MG
    J Transl Med; 2011 Aug; 9():127. PubMed ID: 21806809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
    Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
    Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting of influenza epitopes to murine CR1/CR2 using single-chain antibodies.
    Prechl J; Tchorbanov A; Horváth A; Baiu DC; Hazenbos W; Rajnavölgyi E; Kurucz I; Capel PJ; Erdei A
    Immunopharmacology; 1999 May; 42(1-3):159-65. PubMed ID: 10408376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditional expression of full-length humanized anti-prion protein antibodies in Chinese hamster ovary cells.
    Mueller DA; Heinig L; Ramljak S; Krueger A; Schulte R; Wrede A; Stuke AW
    Hybridoma (Larchmt); 2010 Dec; 29(6):463-72. PubMed ID: 21087094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles.
    Marsac D; Loirat D; Petit C; Schwartz O; Michel ML
    J Virol; 2002 Aug; 76(15):7544-53. PubMed ID: 12097567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP; Doan T; Herd KA; Netter HJ; Tindle RW
    J Virol; 2006 Apr; 80(8):3975-84. PubMed ID: 16571814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene.
    Operschall E; Pavlovic J; Nawrath M; Mölling K
    Intervirology; 2000; 43(4-6):322-30. PubMed ID: 11251388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.